Lasa Supergenerics Reports Mixed Financial Results Amid Declining Sales and Profitability Challenges in August 2025
Lasa Supergenerics has reported its financial results for the quarter ending June 2025, revealing a significant year-on-year increase in Profit After Tax to Rs 9.07 crore. However, the company faced challenges with a 35.12% decline in net sales and a negative operating profit, indicating operational difficulties.
Lasa Supergenerics, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 13, 2025, indicate a notable adjustment in evaluation, with the stock's score reflecting a significant decline over the past three months.The financial data reveals a positive trend in Profit After Tax (PAT), which stands at Rs 9.07 crore, showcasing a substantial year-on-year growth of 197.95%. This figure surpasses the PAT from the preceding twelve-month period, indicating a turnaround in profitability for the company.
Conversely, the results also highlight challenges faced by Lasa Supergenerics. Net sales for the quarter have reached Rs 20.01 crore, marking a year-on-year decline of 35.12% and representing the lowest sales figure in the last five quarters. Additionally, the operating profit has dipped to Rs -0.50 crore, and the operating profit margin has fallen to -2.50%, reflecting a decrease in operational efficiency. Earnings per share have also reached a low of Rs -4.22, indicating a decline in profitability for shareholders.
Overall, Lasa Supergenerics' latest financial results present a mixed picture, with significant evaluation changes noted in its performance metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
